Nov. 2 Media Roundup
Big data was big news last week, with predictions estimating that it may eventually decrease healthcare costs by $400 billion while improving patient outcomes. Based on early victories in applying big data analysis to reduce costs, experts estimate that big data has the potential to decrease healthcare costs between 12% and 17%, leading to savings in the billions.
According to McKesson CIO Kathy McElligott, speaking about the potential of big data analytics, her company is “using analytics to understand what drives the best outcomes—what treatments, medications and processes yield the best outcomes... it’s a huge opportunity to understand what path leads to the highest success.”
mHealth and Tech
- The potential of wearables and the data generated are continuing to generate lots of excitement, including a path to offering a better patient experience.
- Kathy McElligott, CIO at drug distributor McKesson, talks about the opportunity of big data analytics to optimize healthcare.
- Newly available big data in healthcare is growing as quickly as low-cost sensors are being adopted. Predictions now estimate that it may improve patient outcomes and decrease costs by $400 billion or more.
- Lantern has released a mobile program that includes 40 web and mobile sessions which aim to decrease stress and anxiety for users.
- Self-tying shoes have arrived complete with Michael J. Fox showing them off in a Back To The Future throwback.
- Kaiser Permanente found that implementing analytics meant changing its data culture. The takeaway? More eyes on data can lead to more insight.
- San Francisco startup Amino is consumerizing big data to connect patients to better healthcare.
- The next generation of wearables may be an “ingestible.” Jawbone is one of the companies developing tiny robots and sensors that may live in our blood streams or digestives systems.
- Google is developing solar-powered contact lenses which may have the capacity to scan bar codes, authenticate identities, communicate with devices and other features.
Pharma and Life Science
- Thanks to precision medicine, electronic health records may soon include human genomic data.
- Newly FDA approved skin-cancer drug Imlygic –made by Amgen – is opening the door for other cancer-fighting viruses.
- Using technology to be more patient-centric in clinical trial design is continuing to make inroads in the pharma industry.
- Elizabeth McNally, director of NWU’s Center for Genetic Medicine, talks about precision medicine and how it will help the future of disease research.
- Gizmodo spotlighted a video that highlights how each cell in your body – measuring only 10 microns in size –contains two meters of DNA!
- Six new Precision Medicine Centers of Excellence are being founded in the UK with the goal of developing new technology and medicines to improve healthcare.
- President Obama’s precision medicine program is finding lots of support from government agencies, companies and advocacy groups excited about the initiative.
- Is science hacking the human body? A new project is trying to create the ideal NFL athlete using DNA, big data and more.
- What effect does aspirin have on cancer recurrence? In the UK, researchers are starting the world’s largest clinical trial to learn if aspirin can help prevent cancer.